Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 results after 3 years

Authors
Category Primary study
JournalBlood
Year 2011
This article has no abstract
Epistemonikos ID: a546eca4183d19673c2425b6721b1b8dc800c281
First added on: Feb 05, 2025